X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Search Again

We support boolean queries, use +,-,<,>,~,* to alter the weighting of terms

Showing 20 out of 29,158 Resources on page 773

National Drug Code Directory

Drug database published by the Food and Drug Administration of unique universal product identifiers for all drugs manufactured, prepared, propagated, compounded, or processed by it for commercial distribution.

  • Resource
  • SciCrunch
  • 12 years ago - submitted by Yueling Li

Dietary Restriction Gene Database

Database of genes associated with dietary restriction. It includes genes inferred from experiments in model organisms in which genetic manipulations cancel out or disrupt the life-extending effects of dietary restriction and genes robustly altered due to dietary restriction, derived from a meta-analysis of microarray studies in mammals.

  • Resource
  • SciCrunch
  • 12 years ago - submitted by Yueling Li

InterNano Process Database

Database and knowledge base of techniques for processing nanoscale materials, devices, and structures that includes step-by-step descriptions, images, notes on methodology and environmental variables, and associated references and patent information. The purpose of the Process Database is to facilitate the sharing of appropriate process knowledge across laboratories.The processes included here have been previously published or patented

  • Resource
  • SciCrunch
  • 12 years ago - submitted by Yueling Li

FDA Adverse Event Reporting System Data

Database that contains information on adverse event and medication error reports submitted to FDA. The database is designed to support the FDA's post-marketing safety surveillance program for drug and therapeutic biologic products.

  • Resource
  • SciCrunch
  • 12 years ago - submitted by Yueling Li

Cancer Nanotechnology Laboratory (caNanoLab)

Data sharing portal designed to facilitate information sharing across international biomedical nanotechnology research community to expedite and validate use of nanotechnology in biomedicine.

  • Resource
  • SciCrunch
  • 12 years ago - submitted by Yueling Li

ARRS GoldMiner

An image repository that provides access to published, peer-reviewed medical images from biomedical journals.

  • Resource
  • SciCrunch
  • 12 years ago - submitted by Yueling Li

Image Studio Lite

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 28,2023. Software application which can analyze basic Western blot data and export them for use in spreadsheet programs. Users can create standardized or custom lab reports and can share them with colleagues. Image Studio Lite has been discontinued and replaced with Empiria Studio Software.

  • Resource
  • SciCrunch
  • 12 years ago - submitted by Lyndsey Kirk

Osteoarthritis Biomarkers Project (OABP)

The Osteoarthritis Biomarkers Project (OABP) is a consortium designed to identify and classify biological markers of progression of knee osteoarthritis. Their goal is to advance the ability to predict the individual risk of developing severe OA and to monitor progression of OA.


OPTObacteria

The OPTObacteria consortium aims to develop a multianalyte and automatic laboratory detector (ALD) for antibiotic resistant infections. The goal is to detect these analytes within 4-6 hours from the sample collection, providing a report with the actual patient status, and predicting emerging drug resistance through the companion epidemiology software. The platform technology for this consortium is an opto electronic device, in which the appropriate ligand-probe, linked onto an opto electronic surface, will be able of specifically recognize biomolecules of the resistant infections.


Multiple Sclerosis Outcome Assessments Consortium (MSOAC)

The Multiple Sclerosis Outcome Assessments Consortium (MSOAC) is a public-private partnership which aims to accelerate the development of new therapies for MS by generating new tools for measuring outcomes in clinical trials. It is collecting, standardizing, and analyzing data about MS with the goal of qualifying new measures of disability for the disease. MSOAC is the newest of the eight consortia of Critical Path Institute (C-Path), a nonprofit organization that is dedicated to accelerating drug development by delivering on the mission outlined by FDA''''s critical path initiative.


Mendelian Forms of Parkinson's Disease (MEFOPA)

The Collaborative Project on Mendelian Forms of Parkinson's Disease (MEFOPA) is a consortium that advances the basic and clinical research on rare Mendelian forms of Parkinson's disease (PD) by identifying and validating relevant disease-related molecular pathways, drug-targets and biomarkers for disease susceptibility and progression.


Inflammatory Bowel Disease Biomarkers Consortium (IBD BIOM)

The Inflammatory Bowel Disease Biomarkers Consortium (IBD-BIOM) addresses the need to improve our understanding of inflammatory bowel disease (IBD) through new biomarkers into molecular dysfunctions that give rise to IBD. The biomarkers targeted by the consortium will be translated into early-detection clinical diagnostic tests for IBD patients.


Imaging of Neuroinflammation in Neurodegenerative Diseases (INMiND)

The goal of the Imaging of Neuroinflammation in Neurodegenerative Diseases (INMiND) consortium is to identify novel biological targets of neuroinflammation for both diagnostic and therapeutic purposes, and to translate this knowledge into clinical application and patient benefit. The consortium supports collaborative research on molecular mechanisms that link neuroinflammation with neurodegeneration.


Glycomics by High-throughput Integrated Technologies (GLYCOHIT)

The Glycomics by High-throughput Integrated Technologies (GlycoHIT) consortium aims to advance the development of reliable and fast diagnostic tests for the early detection of cancer. By creating high-throughput technologies to analyze altered sugars, or glycobiomarkers, the consortium aims to allow scientists to diagnose different forms of cancer from a simple blood test without the need for biopsy. GlycoHIT will also further develop sugar testing technologies to allow this rapid form of diagnosis to be used in a clinical setting.


Global Research in Paediatrics (GRIP)

The Global Research in Paediatrics (GRiP) consortium focuses on the lack of appropriate testing of pediatric drugs. In particular, most pediatric medications having inadequate information about dosing regimen, dose adjustment and administration. GRiP partners are working to build and maintain an infrastructure matrix, which has the core aim of reducing the current fragmentation of the efforts to study and develop the use of medicine in children. By linking the existing pediatric research networks, GRIP will involve more than 1000 institutions worldwide.


GEUVADIS

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on June 6,2023. A European Medical Sequencing Consortium committed to gaining insights into the human genome and its role in health and medicine by sharing data, experience and expertise in high-throughput sequencing.


NeuroML Database

The NeuroML database is a curated relational database that provides for the storage and retrieval of computational neuroscience models expressed in NeuroML, which is an extensible XML-based language for describing complex mathematical models of neurons and neuronal networks. NeuroML models are unique in their modular and multi-scale structure, where subcomponents of models can correspond to neuroscience models. In particular, the NeuroML database allows for efficient searches over the components of models and metadata that are associated with a hierarchical NeuroML model description.

  • Resource
  • SciCrunch
  • 12 years ago - by Anonymous

G2P Knowledge Centre

Portal of GEN2PHEN project, holistic approach to genotype-to-phenotype data. Aims to unify human and model organism genetic variation databases towards increasingly holistic views into Genotype-To-Phenotype (G2P) data, and to link this system into other biomedical knowledge sources via genome browser functionality.


Genetic Association Information Network (GAIN)

The Genetic Association Information Network (GAIN) supports a series of Genome-Wide Association Studies (GWAS) designed to identify specific points of DNA variation associated with the occurrence of a particular common disease. Initially focusing on six major common diseases, GAIN focused on combining the results with clinical data to create a significant new resource for genetic researchers.


Fatty Liver Inhibition of Progression (FLIP)

The Fatty Liver: Inhibition of Progression consortium (FLIP) aims to study the mechanisms of progression of liver disease in NAFLD to provide strategies for prevention and therapy. The project is based on the largest European cohort of patients with histologically diagnosed NAFLD, assembled with clinical and epidemiological data, and with biobanks of DNA, frozen liver tissue and serum. The consortium''s efforts span all the steps of the disease for studying cellular mechanisms of progression, with a goal of answering key issues dealing with the interplay of metabolic, inflammatory and fibrotic factors in the initiation and perpetuation of liver injury.